SCHEMBL22097130

SCHEMBL22097130

c1ccc(-c2nc(-c3ccc(-c4ccc5c(c4)c4ccccc4c4c5ccc5c6ccccc6n(-c6ccccc6)c54)cc3)nc(-c3ccc(-c4ccccn4)cc3)n2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 4/20 0.37
DHODH Q02127 1/20 0.35
KDM4E B2RXH2 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
ATM Q13315 1/20 0.34
MAPT P10636 5/20 0.34
RAB9A P51151 3/20 0.34
TSHR P16473 2/20 0.34
HSD17B10 Q99714 2/20 0.34
ALDH1A1 P00352 2/20 0.34
HPGD P15428 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
LMNA P02545 1/20 0.34
TP53 P04637 1/20 0.34
PKM P14618 1/20 0.34
KLF5 Q13887 1/20 0.34
MCL1 Q07820 3/20 0.34
MAPK1 P28482 1/20 0.34
KMT2A Q03164 3/20 0.33
PPP1CA P62136 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22097150 0.97 DHODH (0.36) GRM5DHODHKDM4EL3MBTL1ATM
SCHEMBL22097250 0.94 DHODH (0.38) GRM5DHODHKDM4EL3MBTL1ATM
SCHEMBL22097262 0.88 L3MBTL1 (0.41) KDM4EL3MBTL1ATMMAPTRAB9A
SCHEMBL22097203 0.88 L3MBTL1 (0.41) KDM4EL3MBTL1ATMMAPTRAB9A
SCHEMBL22097228 0.88 GRM5 (0.37) GRM5DHODHKDM4EL3MBTL1ATM
SCHEMBL22097012 0.87 MAPT (0.39) KDM4EL3MBTL1ATMMAPTRAB9A
SCHEMBL22097192 0.87 MEN1 (0.40) DHODHKDM4EL3MBTL1ATMMAPT
SCHEMBL22097107 0.87 MEN1 (0.40) DHODHKDM4EL3MBTL1ATMMAPT
SCHEMBL22097074 0.87 L3MBTL1 (0.42) KDM4EL3MBTL1ATMMAPTRAB9A
SCHEMBL22097075 0.87 L3MBTL1 (0.42) KDM4EL3MBTL1ATMMAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11236075-B2 Organic compound and organic electroluminescence device using the same LUMINESCENCE TECHNOLOGY CORP. (TW) 2022-02-01 US disclosed
US-20200190065-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2020-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11236075-B2 Organic compound and organic electroluminescence device using the same ICMT, OR10J3, PIEZO1 GRM5 2552/4885DHODH 583/4885KDM4E 1846/4885
US-20200190065-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME ICMT, OR10J3, PIEZO1 GRM5 2552/4885DHODH 583/4885KDM4E 1846/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.